Xeroflam 3D Tablet is a combination pharmaceutical formulation containing Trypsin (48 mg), Bromelain (90 mg), Rutoside (100 mg), and Diclofenac (50 mg), designed to provide effective anti-inflammatory, analgesic, and fibrinolytic effects. Trypsin and Bromelain are proteolytic enzymes that facilitate the breakdown of proteins and promote the reduction of edema and inflammation by enhancing the absorption of inflammatory exudates. Rutoside, a bioflavonoid, contributes to vascular protection by strengthening capillary walls, reducing permeability, and exhibiting antioxidant properties, thereby aiding in the management of microcirculatory disturbances. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts potent analgesic and anti-inflammatory actions by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), leading to decreased synthesis of prostaglandins involved in pain and inflammation. The synergistic combination of these agents in Xeroflam 3D Tablet makes it suitable for the treatment of acute and chronic inflammatory conditions such as musculoskeletal injuries, postoperative inflammation, and soft tissue trauma. It is recommended to be used under medical supervision, considering contraindications related to NSAIDs and enzyme therapy. Xeroflam 3D Tablet offers a multifaceted approach to inflammation management, promoting faster recovery and symptomatic relief.